GlassScriptPhysician profile
Matthew Folchert
NPI 1275929960
$4,495.94
in general payments reported to CMS, 2019-2025
11 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $202 · 2021: $3,034 · 2022: $753 · 2023: $163 · 2024: $86.79 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,107.72 | 2021 | |
| Axogen | $700.87 | 2021-2022 | |
| Skeletal Dynamics INC | $292.38 | 2021-2023 | Align, Geminus, Ijs |
| Aptis Medical, LLC | $243.43 | 2021 | |
| Endo Pharmaceuticals INC. | $239.13 | 2022-2023 | Xiaflex |
| Stryker Corporation | $231.92 | 2021-2025 | Variax, Axsos, Pangea |
| Acumed LLC | $222.40 | 2020-2023 | Acumed, Osteomed |
| Checkpoint Surgical, INC | $167.21 | 2021-2022 | |
| Bioventus LLC | $114.49 | 2025 | Exogen Ultrasound Bone Healing System |
| Endo USA, INC. | $89.60 | 2025 | Xiaflex |
| Bone Support INC. | $86.79 | 2024 | Ceramentbone Void Filler, Cerament G |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Folchert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.